Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IMP dehydrogenase inhibitors as immunomodulators

B S Mitchell1, J S Dayton, L A Turka

  • 1Department of Pharmacology, University of North Carolina, Chapel Hill 27599.

Annals of the New York Academy of Sciences
|June 23, 1993
PubMed
Summary

Mizoribine, an immunosuppressive drug, inhibits IMP dehydrogenase, depleting guanine ribonucleotides and halting T cell proliferation. This mechanism offers potential for targeted immunosuppression in various conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.

AJNR. American journal of neuroradiology·2017
Same author

Tract-Specific Diffusion Tensor Imaging in Cervical Spondylotic Myelopathy Before and After Decompressive Spinal Surgery: Preliminary Results.

Clinical neuroradiology·2015
Same author

Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells.

Blood cancer journal·2014
Same author

Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.

Leukemia·2013
Same author

Adoption of electronic health records: a qualitative study of academic and private physicians and health administrators.

Applied clinical informatics·2013
Same author

Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Transplant infectious disease : an official journal of the Transplantation Society·2013

Area of Science:

  • Immunology
  • Biochemistry
  • Pharmacology

Background:

  • Inosine monophosphate (IMP) dehydrogenase is crucial for purine biosynthesis, specifically guanine ribonucleotide formation.
  • Mizoribine is an established immunosuppressive agent used clinically, known to inhibit IMP dehydrogenase.

Purpose of the Study:

  • To investigate the effects of mizoribine on human T cell activation and proliferation.
  • To compare the immunosuppressive mechanisms of mizoribine with other purine biosynthesis inhibitors like azathioprine and 6-mercaptopurine.

Main Methods:

  • Human peripheral blood T lymphocytes were stimulated and treated with mizoribine.
  • Cell proliferation, guanine ribonucleotide levels, and cell cycle progression were analyzed.
  • Comparative studies were conducted with azathioprine and 6-mercaptopurine.

Related Experiment Videos

Main Results:

  • Mizoribine dose-dependently inhibited T cell proliferation and decreased guanine ribonucleotide levels.
  • The inhibitory effect of mizoribine was reversible with guanosine supplementation.
  • Mizoribine and mycophenolic acid inhibited proliferation via guanine nucleotide depletion, unlike azathioprine.

Conclusions:

  • Mizoribine inhibits T cell proliferation by depleting guanine ribonucleotides through IMP dehydrogenase inhibition.
  • IMP dehydrogenase inhibitors demonstrate potential as specific immunosuppressive agents.
  • Azathioprine's immunosuppressive mechanism is independent of IMP dehydrogenase inhibition.